Multiplex base editing enhances fetal hemoglobin production in sickle cell disease erythroid cells

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations2021 · 51 citations
2. 2Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34⁺cell therapy to induce fetal hemoglobin for sickle cell disease2024
3. 3Toward ‘n of one’ gene therapies: Scalable ex vivo adenine base editing via lipid nanoparticles in a sickle cell disease model2025 · 1 citations
4. 4Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells2024 · 8 citations
5. 5Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease2024 · 18 citations